Total Payments
$1,763
2024 Payments
$92.00
Companies
6
Transactions
48
Medicare Patients
5,080
Medicare Billing
$406,231
Payment Breakdown by Category
Travel$1,002 (56.9%)
Food & Beverage$760.24 (43.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,002 | 3 | 56.9% |
| Food and Beverage | $760.24 | 45 | 43.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $1,002 | 3 | $0 (2017) |
| LEO Pharma Inc. | $495.94 | 32 | $0 (2022) |
| Incyte Corporation | $89.86 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $85.27 | 4 | $0 (2022) |
| ABBVIE INC. | $64.65 | 3 | $0 (2024) |
| GENZYME CORPORATION | $24.52 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92.00 | 4 | ABBVIE INC. ($47.82) |
| 2023 | $72.37 | 4 | Incyte Corporation ($55.54) |
| 2022 | $188.79 | 12 | LEO Pharma Inc. ($150.75) |
| 2021 | $87.02 | 5 | LEO Pharma Inc. ($87.02) |
| 2020 | $47.04 | 2 | LEO Pharma Inc. ($47.04) |
| 2019 | $135.34 | 11 | LEO Pharma Inc. ($135.34) |
| 2018 | $137.68 | 7 | LEO Pharma Inc. ($75.79) |
| 2017 | $1,002 | 3 | Merck Sharp & Dohme Corporation ($1,002) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: Dermatology | ||||||
| 07/07/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.47 | General |
| Category: Dermatology | ||||||
| 06/21/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Dermatology | ||||||
| 03/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| Category: Dermatology | ||||||
| 09/20/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: DERMATOLOGY | ||||||
| 08/02/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: DERMATOLOGY | ||||||
| 07/12/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: DERMATOLOGY | ||||||
| 05/27/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: DERMATOLOGY | ||||||
| 05/13/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: DERMATOLOGY | ||||||
| 03/19/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: DERMATOLOGY | ||||||
| 02/08/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: DERMATOLOGY | ||||||
| 02/01/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: DERMATOLOGY | ||||||
| 01/22/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: DERMATOLOGY | ||||||
| 01/11/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: DERMATOLOGY | ||||||
| 11/09/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: DERMATOLOGY | ||||||
| 10/18/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: DERMATOLOGY | ||||||
| 06/04/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: DERMATOLOGY | ||||||
| 04/13/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: DERMATOLOGY | ||||||
| 02/12/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,239 | 2,242 | $387,951 | $96,461 |
| 2022 | 14 | 1,233 | 2,419 | $421,151 | $104,744 |
| 2021 | 17 | 1,293 | 2,427 | $431,610 | $111,211 |
| 2020 | 15 | 1,315 | 2,336 | $397,039 | $93,815 |
Total Patients
5,080
Total Services
9,424
Medicare Billing
$406,231
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 383 | 481 | $120,250 | $33,990 | 28.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 221 | 269 | $53,800 | $12,281 | 22.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 116 | 133 | $43,890 | $10,329 | 23.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 57 | 71 | $33,725 | $9,909 | 29.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 90 | 99 | $34,650 | $8,713 | 25.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 174 | 972 | $36,936 | $5,473 | 14.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 28 | 30 | $12,000 | $3,778 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 29 | $8,700 | $2,829 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $11,900 | $2,714 | 22.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 51 | $15,300 | $2,508 | 16.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 31 | 44 | $6,600 | $2,034 | 30.8% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 13 | 15 | $6,000 | $1,135 | 18.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $4,200 | $768.00 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 391 | 542 | $135,500 | $39,235 | 29.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 108 | 141 | $49,350 | $11,517 | 23.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 206 | 268 | $53,600 | $11,469 | 21.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 126 | 152 | $46,260 | $11,146 | 24.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 46 | 60 | $28,500 | $7,495 | 26.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 166 | 1,030 | $39,140 | $5,728 | 14.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 27 | 35 | $14,000 | $4,103 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 36 | $10,800 | $3,588 | 33.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 21 | 22 | $11,000 | $3,236 | 29.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 40 | 61 | $9,150 | $2,843 | 31.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 35 | 35 | $10,500 | $1,913 | 18.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $3,751 | $1,040 | 27.7% |
About Dr. Robert Brown, MD
Dr. Robert Brown, MD is a Dermatology healthcare provider based in Brighton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104995133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Brown, MD has received a total of $1,763 in payments from pharmaceutical and medical device companies, with $92.00 received in 2024. These payments were reported across 48 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($1,002).
As a Medicare-enrolled provider, Brown has provided services to 5,080 Medicare beneficiaries, totaling 9,424 services with total Medicare billing of $406,231. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Brighton, MA
- Active Since 11/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1104995133
Products in Payments
- ENSTILAR (Drug) $241.18
- ADBRY (Biological) $150.75
- PICATO (Drug) $104.01
- OPZELURA (Drug) $89.86
- COSENTYX (Biological) $85.27
- SKYRIZI (Biological) $64.65
- DUPIXENT (Biological) $24.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Brighton
Mark Amster, Md, MD
Dermatology — Payments: $366,491
Dermatology $366,491
Dr. Howard Lipkin, D.o, D.O
Dermatology — Payments: $59,877
Dermatology $59,877
Mrs. Caitlin Porubsky, D.o, D.O
Dermatology — Payments: $14,577
Dermatology $14,577
Mrs. Jennifer Gangnier, Pa-C, PA-C
Dermatology — Payments: $4,155
Dermatology $4,155
Elizabeth Messenger, Md, MD
Dermatology — Payments: $1,970
Dermatology $1,970
Dr. Claudette Mcgoey, M.d, M.D
Dermatology
Dermatology